AMRX
Amneal Pharmaceuticals, Inc.
Next earnings Aug 3, 2026 · consensus $0.23 EPS, $776M rev
Last earnings +0.7% on 2026-05-07
$17.32
▲ +3.96%$16.66▲ +110.89%
over 1Y
L $7.82EODHDH $16.66
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+4.0%
1W+2.5%
1M+30.3%
3M+38.0%
YTD+31.6%
1Y+110.9%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Diversified generics maker turning the corner to profitability and growth — but $2.57B debt and negative equity weigh.
The read
Sources: SEC EDGAR (CIK 0001723128, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/21/2026, 8:59:10 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.